While higher blood DNA methylation levels at CPT1A markers were associated with lower IR, higher levels of brain DNA methylation at the same markers were associated with higher values of clinical diagnosis of cognitive status and AD-related indices in ROSMAP, suggesting potentially different and tissue-specific epigenetic regulations at this locus. The gene discussed is CPT1A; the disease is Alzheimer disease.